Covid-19 pandemic may shift to endemic in 2022, Moderna chair says

14/1/2022 4:25:00 PM
Covid-19 pandemic may shift to endemic in 2022, Moderna chair says

Covid-19 pandemic may shift to endemic in 2022, Moderna chair says

https://str.sg/wQUyMASSACHUSETTES, New England (BLOOMBERG) - The pandemic could start moving into an endemic phase in 2022, though countries will need to stay vigilant as the Omicron variant spreads, according to Moderna Inc co-founder Noubar Afeyan.While some countries slowly begin to consider treating Covid-19 as an endemic disease, like the flu, World Health Organisation officials have said it's too early to make that call as cases surge.

"2022 may be the year that the pandemic enters an endemic phase, but it really depends on what happens and the decisions that are made across the world," Afeyan said in a Bloomberg Television interview Friday with Francine Lacqua. Although Omicron is highly transmissible,"on the other hand it's having a lesser effect in terms of seriousness of disease," he said.

Read more: ST Foreign Desk »

Man 'bullies' MRT passenger into saying 'I'm a coward, I'm a coward'

Is this bullying? Read more at stomp.straitstimes.com Read more >>

But makes no mention of the Omicron Variant being a much more effective vaccine whilst being less dangerous

Moderna expects Covid-19 vaccine trial data for children aged 2-5 in MarchCAMBRIDGE, Massachusetts — Moderna said on Wednesday (Jan 12) it expects to report data from its Covid-19 vaccine trial in children aged between 2 to 5 years in March.

WHO recommends Eli Lilly, GSK-Vir's drugs, widening COVID-19 treatment poolA World Health Organization (WHO) panel recommended use of two drugs by Eli Lilly, and GlaxoSmithKline and Vir Biotechnology for COVID-19 patients, adding treatment options as the fast-spreading Omicron variant renders many ineffective. WHO data shows Omicron, which is evading protection provided by many v

Daily Covid-19 Omicron count in S'pore nearly doubles to 797 infections

Pfizer study shows Covid-19 booster can be given along with pneumonia shot

882 new COVID-19 cases in Singapore; 797 Omicron infections confirmed

882 new COVID-19 cases in Singapore; 797 Omicron infections confirmedSINGAPORE: Singapore reported 882 new COVID-19 cases as of noon on Wednesday (Jan 12), including 396 imported infections. There was one fatality, taking the country\u0027s death toll from coronavirus complications to 839, according to the latest infection statistics on the Ministry of Healt And how many was diagnosed with more life threatening diseases testerday such as cancer, diabetes & liver failure? When will this fear propaganda end? Covid is here to stay. So be it, instead of living ones life trying to avoid the inevitable, we shud move towards resilience... Of course in HK (larger population), with only 21 cases (16 imported and 5 linked to CX staff breaches and quarantine loopholes) we look like Loosers ... ...but here life is pretty much cool with 426 in hospitals... MadameButcher all vaccinated. time to ban vaccinated people from going to work

PSG postpone Qatar winter tour amid rising COVID-19 casesParis Saint-Germain have postponed their Qatar winter tour as COVID-19 cases continue to rise, the French club said on Wednesday.France registered a record of nearly 370,000 infections on Tuesday, while the seven-day average of new infections set a new high of more than 283,000.'In view of the heal

Copy to clipboard https://str."If the data is supportive and subject to regulatory consultation, Moderna may proceed with regulatory filings for children 2-5 years of age thereafter," the company said.LinkedIn A World Health Organization (WHO) panel recommended use of two drugs by Eli Lilly, and GlaxoSmithKline and Vir Biotechnology for COVID-19 patients, adding treatment options as the fast-spreading Omicron variant renders many ineffective.Copy to clipboard https://str.

sg/wQUy MASSACHUSETTES, New England (BLOOMBERG) - The pandemic could start moving into an endemic phase in 2022, though countries will need to stay vigilant as the Omicron variant spreads, according to Moderna Inc co-founder Noubar Afeyan. While some countries slowly begin to consider treating Covid-19 as an endemic disease, like the flu, World Health Organisation officials have said it's too early to make that call as cases surge. In the United States, the vaccine is authorized by Food and Drug Administration as primary two-dose regimen and booster dose for adults 18 years and older. "2022 may be the year that the pandemic enters an endemic phase, but it really depends on what happens and the decisions that are made across the world," Afeyan said in a Bloomberg Television interview Friday with Francine Lacqua. The panel on Thursday (Jan 13) strongly recommended Lilly's baricitinib, sold under brand name Olumiant, for patients with severe COVID-19 in combination with corticosteroids, while conditionally endorsed GSK-Vir's antibody therapy for non-severe patients at the highest risk of hospitalisation. Although Omicron is highly transmissible,"on the other hand it's having a lesser effect in terms of seriousness of disease," he said. REUTERS Related topics. Moderna's Omicron-specific booster shot could enter into human trials within weeks, he said, reiterating comments Chief Executive Officer Stephane Bancel made earlier this week. The weekly Covid-19 infection growth rate dipped slightly to 1.

The CEO said he expected another booster would be needed in the fall, and it is likely to contain a component tailored to Omicron. The WHO guidelines, published in the British Medical Journal, also noted that evidence shows baricitinib improves survival rate and reduces the need for ventilation, with no observed increase in adverse effects. "We will be ready with our testing starting in weeks," Afeyan said Friday."Whether we need a booster rather in the spring than the fall is something that we're going to have to work with officials all around the world to sort out." Shares of Moderna declined 3. Related:.3 per cent in pre-market trading in New York. There were 167 patients in hospital, with 13 requiring oxygen supplementation and 11 in the intensive care unit.

Moderna, along with Pfizer and its partner BioNTech, developed highly effective Covid-19 vaccines based on messenger RNA technology. Moderna said earlier this week that it has signed vaccine purchase agreements worth US$18.5 billion (S$24.9 billion) for this year, along with options for another US$3.5 billion, including booster shots.

More On This Topic .